Global Aflibercept Drug Market Research Report 2023

December 2023 | 67 pages | ID: G00367B3E4AEEN
QYResearch

Abstracts

Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer.

According to QYResearch’s new survey, global Aflibercept Drug market is projected to reach US$ 7305.9 million in 2029, increasing from US$ 5617 million in 2022, with the CAGR of 3.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aflibercept Drug market research.

The Eylea market is primarily driven by the increasing prevalence of retinal diseases and the demand for effective treatments. Eylea (aflibercept) is a medication used to treat various eye conditions, including wet age-related macular degeneration (AMD) and diabetic macular edema. The growing aging population and the rise in chronic diseases like diabetes contribute to market growth. Moreover, advancements in ocular therapeutics and the demonstrated efficacy of Eylea in improving visual outcomes further propel adoption. However, challenges include managing the high cost of treatment and ensuring equitable access to care. Navigating the competitive landscape, optimizing treatment protocols, and addressing potential side effects are ongoing concerns. The market's success relies on continuous research to expand the indications for Eylea, collaborations between pharmaceutical manufacturers and ophthalmologists, and comprehensive patient education on the benefits and potential risks of treatment while addressing the evolving challenges associated with retinal disease management and treatment affordability.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Aflibercept Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Regeneron
• Bayer
• Sanofi

Segment by Type

• Prefilled Syring Package
• Vial Package

Segment by Application

• Eye Disease
• Cancer

Consumption by Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• China Taiwan
• Indonesia
• Thailand
• Malaysia
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE

The Aflibercept Drug report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers’ Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers’ Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Contents

1 AFLIBERCEPT DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Aflibercept Drug
1.2 Aflibercept Drug Segment by Type
  1.2.1 Global Aflibercept Drug Market Value Comparison by Type (2023-2029)
  1.2.2 Prefilled Syring Package
  1.2.3 Vial Package
1.3 Aflibercept Drug Segment by Application
  1.3.1 Global Aflibercept Drug Market Value by Application: (2023-2029)
  1.3.2 Eye Disease
  1.3.3 Cancer
1.4 Global Aflibercept Drug Market Size Estimates and Forecasts
  1.4.1 Global Aflibercept Drug Revenue 2018-2029
  1.4.2 Global Aflibercept Drug Sales 2018-2029
  1.4.3 Global Aflibercept Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations

2 AFLIBERCEPT DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Aflibercept Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Aflibercept Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Aflibercept Drug Average Price by Manufacturers (2018-2023)
2.4 Global Aflibercept Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Aflibercept Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aflibercept Drug, Product Type & Application
2.7 Aflibercept Drug Market Competitive Situation and Trends
  2.7.1 Aflibercept Drug Market Concentration Rate
  2.7.2 The Global Top 5 and Top 10 Largest Aflibercept Drug Players Market Share by Revenue
  2.7.3 Global Aflibercept Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 AFLIBERCEPT DRUG RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Aflibercept Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Aflibercept Drug Global Aflibercept Drug Sales by Region: 2018-2029
  3.2.1 Global Aflibercept Drug Sales by Region: 2018-2023
  3.2.2 Global Aflibercept Drug Sales by Region: 2024-2029
3.3 Global Aflibercept Drug Global Aflibercept Drug Revenue by Region: 2018-2029
  3.3.1 Global Aflibercept Drug Revenue by Region: 2018-2023
  3.3.2 Global Aflibercept Drug Revenue by Region: 2024-2029
3.4 North America Aflibercept Drug Market Facts & Figures by Country
  3.4.1 North America Aflibercept Drug Market Size by Country: 2018 VS 2022 VS 2029
  3.4.2 North America Aflibercept Drug Sales by Country (2018-2029)
  3.4.3 North America Aflibercept Drug Revenue by Country (2018-2029)
  3.4.4 United States
  3.4.5 Canada
3.5 Europe Aflibercept Drug Market Facts & Figures by Country
  3.5.1 Europe Aflibercept Drug Market Size by Country: 2018 VS 2022 VS 2029
  3.5.2 Europe Aflibercept Drug Sales by Country (2018-2029)
  3.5.3 Europe Aflibercept Drug Revenue by Country (2018-2029)
  3.5.4 Germany
  3.5.5 France
  3.5.6 U.K.
  3.5.7 Italy
  3.5.8 Russia
3.6 Asia Pacific Aflibercept Drug Market Facts & Figures by Country
  3.6.1 Asia Pacific Aflibercept Drug Market Size by Country: 2018 VS 2022 VS 2029
  3.6.2 Asia Pacific Aflibercept Drug Sales by Country (2018-2029)
  3.6.3 Asia Pacific Aflibercept Drug Revenue by Country (2018-2029)
  3.6.4 China
  3.6.5 Japan
  3.6.6 South Korea
  3.6.7 India
  3.6.8 Australia
  3.6.9 China Taiwan
  3.6.10 Indonesia
  3.6.11 Thailand
  3.6.12 Malaysia
3.7 Latin America Aflibercept Drug Market Facts & Figures by Country
  3.7.1 Latin America Aflibercept Drug Market Size by Country: 2018 VS 2022 VS 2029
  3.7.2 Latin America Aflibercept Drug Sales by Country (2018-2029)
  3.7.3 Latin America Aflibercept Drug Revenue by Country (2018-2029)
  3.7.4 Mexico
  3.7.5 Brazil
  3.7.6 Argentina
3.8 Middle East and Africa Aflibercept Drug Market Facts & Figures by Country
  3.8.1 Middle East and Africa Aflibercept Drug Market Size by Country: 2018 VS 2022 VS 2029
  3.8.2 Middle East and Africa Aflibercept Drug Sales by Country (2018-2029)
  3.8.3 Middle East and Africa Aflibercept Drug Revenue by Country (2018-2029)
  3.8.4 Turkey
  3.8.5 Saudi Arabia
  3.8.6 UAE

4 SEGMENT BY TYPE

4.1 Global Aflibercept Drug Sales by Type (2018-2029)
  4.1.1 Global Aflibercept Drug Sales by Type (2018-2023)
  4.1.2 Global Aflibercept Drug Sales by Type (2024-2029)
  4.1.3 Global Aflibercept Drug Sales Market Share by Type (2018-2029)
4.2 Global Aflibercept Drug Revenue by Type (2018-2029)
  4.2.1 Global Aflibercept Drug Revenue by Type (2018-2023)
  4.2.2 Global Aflibercept Drug Revenue by Type (2024-2029)
  4.2.3 Global Aflibercept Drug Revenue Market Share by Type (2018-2029)
4.3 Global Aflibercept Drug Price by Type (2018-2029)

5 SEGMENT BY APPLICATION

5.1 Global Aflibercept Drug Sales by Application (2018-2029)
  5.1.1 Global Aflibercept Drug Sales by Application (2018-2023)
  5.1.2 Global Aflibercept Drug Sales by Application (2024-2029)
  5.1.3 Global Aflibercept Drug Sales Market Share by Application (2018-2029)
5.2 Global Aflibercept Drug Revenue by Application (2018-2029)
  5.2.1 Global Aflibercept Drug Revenue by Application (2018-2023)
  5.2.2 Global Aflibercept Drug Revenue by Application (2024-2029)
  5.2.3 Global Aflibercept Drug Revenue Market Share by Application (2018-2029)
5.3 Global Aflibercept Drug Price by Application (2018-2029)

6 KEY COMPANIES PROFILED

6.1 Regeneron
  6.1.1 Regeneron Corporation Information
  6.1.2 Regeneron Description and Business Overview
  6.1.3 Regeneron Aflibercept Drug Sales, Revenue and Gross Margin (2018-2023)
  6.1.4 Regeneron Aflibercept Drug Product Portfolio
  6.1.5 Regeneron Recent Developments/Updates
6.2 Bayer
  6.2.1 Bayer Corporation Information
  6.2.2 Bayer Description and Business Overview
  6.2.3 Bayer Aflibercept Drug Sales, Revenue and Gross Margin (2018-2023)
  6.2.4 Bayer Aflibercept Drug Product Portfolio
  6.2.5 Bayer Recent Developments/Updates
6.3 Sanofi
  6.3.1 Sanofi Corporation Information
  6.3.2 Sanofi Description and Business Overview
  6.3.3 Sanofi Aflibercept Drug Sales, Revenue and Gross Margin (2018-2023)
  6.3.4 Sanofi Aflibercept Drug Product Portfolio
  6.3.5 Sanofi Recent Developments/Updates

7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

7.1 Aflibercept Drug Industry Chain Analysis
7.2 Aflibercept Drug Key Raw Materials
  7.2.1 Key Raw Materials
  7.2.2 Raw Materials Key Suppliers
7.3 Aflibercept Drug Production Mode & Process
7.4 Aflibercept Drug Sales and Marketing
  7.4.1 Aflibercept Drug Sales Channels
  7.4.2 Aflibercept Drug Distributors
7.5 Aflibercept Drug Customers

8 AFLIBERCEPT DRUG MARKET DYNAMICS

8.1 Aflibercept Drug Industry Trends
8.2 Aflibercept Drug Market Drivers
8.3 Aflibercept Drug Market Challenges
8.4 Aflibercept Drug Market Restraints

9 RESEARCH FINDING AND CONCLUSION


10 METHODOLOGY AND DATA SOURCE

10.1 Methodology/Research Approach
  10.1.1 Research Programs/Design
  10.1.2 Market Size Estimation
  10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
  10.2.1 Secondary Sources
  10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Aflibercept Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Aflibercept Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Aflibercept Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Aflibercept Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Aflibercept Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Aflibercept Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Aflibercept Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Aflibercept Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Aflibercept Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Aflibercept Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aflibercept Drug, Product Type & Application
Table 12. Global Key Manufacturers of Aflibercept Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aflibercept Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflibercept Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aflibercept Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Aflibercept Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global Aflibercept Drug Sales Market Share by Region (2018-2023)
Table 19. Global Aflibercept Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Aflibercept Drug Sales Market Share by Region (2024-2029)
Table 21. Global Aflibercept Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Aflibercept Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Aflibercept Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Aflibercept Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Aflibercept Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Aflibercept Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America Aflibercept Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Aflibercept Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Aflibercept Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Aflibercept Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Aflibercept Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe Aflibercept Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Aflibercept Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Aflibercept Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Aflibercept Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Aflibercept Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Aflibercept Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Aflibercept Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Aflibercept Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Aflibercept Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Aflibercept Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Aflibercept Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Aflibercept Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Aflibercept Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Aflibercept Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Aflibercept Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Aflibercept Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Aflibercept Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Aflibercept Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Aflibercept Drug Sales (K Units) by Type (2018-2023)
Table 51. Global Aflibercept Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Aflibercept Drug Sales Market Share by Type (2018-2023)
Table 53. Global Aflibercept Drug Sales Market Share by Type (2024-2029)
Table 54. Global Aflibercept Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Aflibercept Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Aflibercept Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Aflibercept Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Aflibercept Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global Aflibercept Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Aflibercept Drug Sales (K Units) by Application (2018-2023)
Table 61. Global Aflibercept Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Aflibercept Drug Sales Market Share by Application (2018-2023)
Table 63. Global Aflibercept Drug Sales Market Share by Application (2024-2029)
Table 64. Global Aflibercept Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Aflibercept Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Aflibercept Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Aflibercept Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Aflibercept Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global Aflibercept Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Regeneron Corporation Information
Table 71. Regeneron Description and Business Overview
Table 72. Regeneron Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Regeneron Aflibercept Drug Product
Table 74. Regeneron Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Bayer Aflibercept Drug Product
Table 79. Bayer Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Aflibercept Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Aflibercept Drug Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Aflibercept Drug Distributors List
Table 88. Aflibercept Drug Customers List
Table 89. Aflibercept Drug Market Trends
Table 90. Aflibercept Drug Market Drivers
Table 91. Aflibercept Drug Market Challenges
Table 92. Aflibercept Drug Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Aflibercept Drug
Figure 2. Global Aflibercept Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Aflibercept Drug Market Share by Type in 2022 & 2029
Figure 4. Prefilled Syring Package Product Picture
Figure 5. Vial Package Product Picture
Figure 6. Global Aflibercept Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Aflibercept Drug Market Share by Application in 2022 & 2029
Figure 8. Eye Disease
Figure 9. Cancer
Figure 10. Global Aflibercept Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Aflibercept Drug Market Size (2018-2029) & (US$ Million)
Figure 12. Global Aflibercept Drug Sales (2018-2029) & (K Units)
Figure 13. Global Aflibercept Drug Average Price (US$/Unit) & (2018-2029)
Figure 14. Aflibercept Drug Report Years Considered
Figure 15. Aflibercept Drug Sales Share by Manufacturers in 2022
Figure 16. Global Aflibercept Drug Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Aflibercept Drug Players: Market Share by Revenue in 2022
Figure 18. Aflibercept Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Aflibercept Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Aflibercept Drug Sales Market Share by Country (2018-2029)
Figure 21. North America Aflibercept Drug Revenue Market Share by Country (2018-2029)
Figure 22. United States Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Aflibercept Drug Sales Market Share by Country (2018-2029)
Figure 25. Europe Aflibercept Drug Revenue Market Share by Country (2018-2029)
Figure 26. Germany Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Aflibercept Drug Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Aflibercept Drug Revenue Market Share by Region (2018-2029)
Figure 33. China Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Aflibercept Drug Sales Market Share by Country (2018-2029)
Figure 43. Latin America Aflibercept Drug Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Aflibercept Drug Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Aflibercept Drug Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Aflibercept Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Aflibercept Drug by Type (2018-2029)
Figure 53. Global Revenue Market Share of Aflibercept Drug by Type (2018-2029)
Figure 54. Global Aflibercept Drug Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Aflibercept Drug by Application (2018-2029)
Figure 56. Global Revenue Market Share of Aflibercept Drug by Application (2018-2029)
Figure 57. Global Aflibercept Drug Price (US$/Unit) by Application (2018-2029)
Figure 58. Aflibercept Drug Value Chain
Figure 59. Aflibercept Drug Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed